BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32606318)

  • 21. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
    Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
    Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of PRL3 expression with colorectal cancer progression.
    Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Black JD; Wang J; Are C
    J Surg Oncol; 2021 Jan; 123(1):42-51. PubMed ID: 33179291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
    De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
    Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis.
    Poglio S; Cahu X; Uzan B; Besnard-Guérin C; Lapillonne H; Leblanc T; Baruchel A; Landman-Parker J; Petit A; Baleydier F; Amsellem S; Baud V; Ballerini P; Pflumio F
    Leukemia; 2015 Apr; 29(4):977-80. PubMed ID: 25371179
    [No Abstract]   [Full Text] [Related]  

  • 25. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
    Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
    Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
    Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
    Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
    Thura M; Al-Aidaroos AQ; Gupta A; Chee CE; Lee SC; Hui KM; Li J; Guan YK; Yong WP; So J; Chng WJ; Ng CH; Zhou J; Wang LZ; Yuen JSP; Ho HSS; Yi SM; Chiong E; Choo SP; Ngeow J; Ng MCH; Chua C; Yeo ESA; Tan IBH; Sng JXE; Tan NYZ; Thiery JP; Goh BC; Zeng Q
    Nat Commun; 2019 Jun; 10(1):2484. PubMed ID: 31171773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
    Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
    Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
    Pitt LA; Tikhonova AN; Hu H; Trimarchi T; King B; Gong Y; Sanchez-Martin M; Tsirigos A; Littman DR; Ferrando AA; Morrison SJ; Fooksman DR; Aifantis I; Schwab SR
    Cancer Cell; 2015 Jun; 27(6):755-68. PubMed ID: 26058075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.
    Shen Y; Park CS; Suppipat K; Mistretta TA; Puppi M; Horton TM; Rabin K; Gray NS; Meijerink JPP; Lacorazza HD
    Leukemia; 2017 Jun; 31(6):1314-1324. PubMed ID: 27872496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
    Sun W; Zhang Y; Wong KC; Liu K; Yang Y; Wu B; Tong JHM; Chan AWH; Chan HLY; Yu J
    Hepatology; 2018 Jun; 67(6):2302-2319. PubMed ID: 29266303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
    Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
    Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.
    Marín-Rubio JL; Pérez-Gómez E; Fernández-Piqueras J; Villa-Morales M
    Carcinogenesis; 2019 Oct; 40(10):1260-1268. PubMed ID: 30805584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch in Leukemia.
    McCarter AC; Wang Q; Chiang M
    Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia.
    Gao X; Qin S; Wu Y; Chu C; Jiang B; Johnson RH; Kuang D; Zhang J; Wang X; Mehta A; Tew KD; Leone GW; Yu XZ; Wang H
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34255748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
    Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
    Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.
    Anand P; Guillaumet-Adkins A; Dimitrova V; Yun H; Drier Y; Sotudeh N; Rogers A; Ouseph MM; Nair M; Potdar S; Isenhart R; Kloeber JA; Vijaykumar T; Niu L; Vincent T; Guo G; Frede J; Harris MH; Place AE; Silverman LB; Teachey DT; Lane AA; DeAngelo DJ; Aster JC; Bernstein BE; Lohr JG; Knoechel B
    Blood; 2021 May; 137(18):2463-2480. PubMed ID: 33227818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.